Biotech Chinook Therapeutics Receives Orphan Drug Designation from European Commission for BION-1301 for Treatment of Primary IgA Nephropathy (IgAN) July 5, 2022
Biotech Chinook Therapeutics to Present at the William Blair Biotech Focus Conference 2022 July 5, 2022